Hyderabad-based pharma player Laurus Labs has received a licence from the Defence Research & Development Organisation (DRDO) for manufacturing and marketing Covid-19 drug 2-Deoxy-D-Glucose (2-DG) in India. The licence to Laurus Labs has been granted by DRDO as part of efforts to make the drug affordable and accessible to patients.
DRDO had recently invited expression of interest (EoI) from other pharma companies for manufacturing this drug and had said it would grant licences to 15 companies on a first-come, first-served basis. Meanwhile, the Council of Scientific & Industrial Research institution Indian Institute of Chemical Technology (CSIR-IICT) has been licencing the know-how for 2-DG synthesis to other companies, including Lee Pharma, Suven Pharma, Anthem Biosciences and Nosch Labs.
Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…
On June 21st every year millions of people celebrate International Yoga Day by practicing the…
On 21st June, millions of the people around the world celebrates Father’s Day by expressing…
On 21st June, International Yoga Day observed and it will bring together the millions of…
National News Supreme Court Declares Right to Walk Safely a Fundamental Right The Supreme Court…
India has inducted its first homegrown hovercraft into the Indian Coast Guard. This newly inducted…